A Professional Standard for Informed Consent for Stem Cell Therapies
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Barker, Roger https://orcid.org/0000-0001-8843-7730
Abstract
In November 2018, the US Food & Drug Administration (FDA) issued a press release that stated: “The potential health benefits of regenerative medicine have spurred major progress in stem-cell biology over the past several decades. But we continue to see bad actors exploit the scientific promise of this field to mislead vulnerable patients into believing they’re being given safe, effective treatments; when instead these stem cell producers are leveraging the field’s hype to push unapproved, unproven, illegal, and potentially unsafe products."
Description
Keywords
StemCellInstitute
Journal Title
JAMA - Journal of the American Medical Association
Conference Name
Journal ISSN
1538-3598
1538-3598
1538-3598
Volume Title
332
Publisher
American Medical Association
Publisher DOI
Rights
All rights reserved
Sponsorship
Medical Research Council (MC_PC_12009)
None